The Board of the Georgetown Public Hospital Corporation (GPHC) investigated the circumstances surrounding the procurement of drugs and medical supplies early this year in the sum of $632 million. The Board found that the Chief Executive Officer (CEO) acted “recklessly” in initiating the procurement but did not find any evidence that the Minister of Public Health gave any instructions for the procurement procedures to be bypassed.
The violations relate to the failure to follow the following: public advertisement inviting suppliers to tender for the supply of the specified items;
